Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy
โ Scribed by James A. Martenson; Thomas G. Shanahan; Michael J. O'Connell; Charles D. Cobau; Georgene Schroeder; Patrick A. Burch; Ralph Levitt; Kendrith M. Rowland Jr.
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 63 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
BACKGROUND.
This study was designed to assess the toxicity of pelvic radiation therapy, 5-fluorouracil (5-FU) administered by protracted venous infusion, and leucovorin.
METHODS.
Pelvic radiation therapy consisted of 50.4 -54 gray (Gy) administered in 28 -30 fractions. Systemic treatment consisted of leucovorin (10 mg daily) administered orally and protracted venous infusion of 5-FU. The initial daily 5-FU dose was 150 mg/m 2 . Dose escalations were planned in increments of 25 mg/m 2 .
๐ SIMILAR VOLUMES
## BACKGROUND. The aim of this study was to define the maximum tolerated doses